ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
139 hedge funds and large institutions have $755M invested in Intra-Cellular Therapies Inc. in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 64 increasing their positions, 26 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
42% less capital invested
Capital invested by funds: $1.3B → $755M (-$546M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
139
Holding in Top 10
2
Calls
$10.9M
Puts
$7.69M
Top Buyers
| 1 | +$21.8M | |
| 2 | +$21M | |
| 3 | +$17.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16M |
| 5 |
SC
Samlyn Capital
New York
|
+$13.6M |
Top Sellers
| 1 | -$20.1M | |
| 2 | -$13.9M | |
| 3 | -$6.93M | |
| 4 |
Morgan Stanley
New York
|
-$5.62M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.56M |